Michel Arvidsson | Karolinska Institutet

Publications
CV
Public outreach and news

Articles

Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022;130(4):492-500
Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity
Arvidsson M; Franck J; Ackehed G; Bergstrand MP; Ekstrom L; Rosenborg S; Dahl M-L
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2020;76(2):229-237
Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers
Arvidsson M; Dahl M-L; Beck O; Ackehed G; Nordin K; Rosenborg S
Article: NORDIC JOURNAL OF PSYCHIATRY. 2019;73(2):118-124
Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study
Arvidsson M; Dahl M-L; Franck J; Wiig EH; Nielsen NP
Article: DRUG TESTING AND ANALYSIS. 2019;11(1):27-32
Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder
Arvidsson M; Ullah S; Franck J; Dahl M-L; Beck O

All other publications

Doctoral thesis: 2024
Enantiomeric pharmacokinetics of methylphenidate and processing speed measures in adults with ADHD and substance use disorders
Arvidsson M
Conference publication: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75:S89-S90
Pharmacokinetics of methylphenidate in plasma, exhaled breath, oral fluid and dried blood spots after a single oral dose of ritalin 20 mg
Arvidsson M; Dahl M-L; Beck O; Rosenborg S; Nordin K; Lenk G

Employments

Affiliated to Research, Department of Laboratory Medicine, Karolinska Institutet, 2023-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Laboratory Medicine, Karolinska Institutet, 2024

News from KI

Events from KI